{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T13:34:58Z","timestamp":1790948098291,"version":"4.1.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,6,10]],"date-time":"2020-06-10T00:00:00Z","timestamp":1591747200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006483","name":"AbbVie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006483","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["kidneymedicinejournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney Medicine"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.xkme.2020.05.009","type":"journal-article","created":{"date-parts":[[2020,6,16]],"date-time":"2020-06-16T21:59:11Z","timestamp":1592344751000},"page":"450-458","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Vitamin D Analogues and Coronary Calcification in CKD Stages 3 and 4: A Randomized Controlled Trial of Calcitriol Versus Paricalcitol"],"prefix":"10.1016","volume":"2","author":[{"given":"Karim H.","family":"Anis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Pober","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvia E.","family":"Rosas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xkme.2020.05.009_bib1","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1681\/ASN.2014020173","article-title":"Subclinical atherosclerosis measures for cardiovascular prediction in CKD","volume":"26","author":"Matsushita","year":"2015","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.xkme.2020.05.009_bib2","doi-asserted-by":"crossref","first-page":"S142","DOI":"10.1053\/ajkd.1998.v32.pm9820472","article-title":"Hyperlipidemia in patients with chronic renal disease","volume":"2(5 suppl 3)","author":"Kasiske","year":"1998","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.xkme.2020.05.009_bib3","series-title":"USRDS 2005 Annual Data Report","year":"2005"},{"key":"10.1016\/j.xkme.2020.05.009_bib4","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1001\/jamacardio.2017.0363","article-title":"Coronary artery calcification and risk of cardiovascular disease and death among patients with chronic kidney disease","volume":"2","author":"Chen","year":"2017","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.xkme.2020.05.009_bib5","first-page":"S1","article-title":"KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD)","volume":"1","year":"2009","journal-title":"Kidney Int Suppl"},{"key":"10.1016\/j.xkme.2020.05.009_bib6","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/sj.ki.5002406","article-title":"Differential effects of vitamin D receptor activators on vascular calcification in uremic rats","volume":"72","author":"Mizobuchi","year":"2007","journal-title":"Kidney Int"},{"key":"10.1016\/j.xkme.2020.05.009_bib7","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1159\/000266204","article-title":"Differential effects of paricalcitol and calcitriol on intestinal calcium absorption in hemodialysis patients","volume":"31","author":"Lund","year":"2010","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.xkme.2020.05.009_bib8","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1067\/mlc.2002.122819","article-title":"Differential effects of 19-nor-1,25-dihydroxyvitamin D2 and 1,25-dihydroxyvitamin D3 on intestinal calcium and phosphate transport","volume":"139","author":"Brown","year":"2002","journal-title":"J\u00a0Lab Clin Med"},{"key":"10.1016\/j.xkme.2020.05.009_bib9","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1681\/ASN.V105980","article-title":"Differential effects of 1,25-dihydroxy-vitamin D3 and 19-nor-1, 25-dihydroxy-vitamin D2 on calcium and phosphorus resorption in bone","volume":"10","author":"Finch","year":"1999","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.xkme.2020.05.009_bib10","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/0272-6386(95)90455-7","article-title":"A\u00a0new analog of calcitriol, 19-nor-1, 25-(OH) 2 D 2, suppresses parathyroid hormone secretion in uremic rats in the absence of hypercalcemia","volume":"26","author":"Slatopolsky","year":"1995","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.xkme.2020.05.009_bib11","doi-asserted-by":"crossref","first-page":"16810","DOI":"10.1073\/pnas.0611202104","article-title":"Activated vitamin D attenuates left ventricular abnormalities induced by dietary sodium in Dahl salt-sensitive animals","volume":"104","author":"Bodyak","year":"2007","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"key":"10.1016\/j.xkme.2020.05.009_bib12","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1056\/NEJMoa022536","article-title":"Survival of patients undergoing hemodialysis with paricalcitol or calcitriol therapy","volume":"349","author":"Teng","year":"2003","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.xkme.2020.05.009_bib13","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.2215\/CJN.10661013","article-title":"A\u00a0randomized multicenter trial of paricalcitol versus calcitriol for secondary hyperparathyroidism in stages 3-4 CKD","volume":"9","author":"Coyne","year":"2014","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.xkme.2020.05.009_bib14","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1001\/jama.2012.120","article-title":"Vitamin D therapy and cardiac structure and function in patients with chronic kidney disease: the PRIMO randomized controlled trial","volume":"307","author":"Thadhani","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.xkme.2020.05.009_bib15","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1681\/ASN.2004070610","article-title":"Association between chronic kidney disease and coronary artery calcification: the Dallas Heart Study","volume":"16","author":"Kramer","year":"2005","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.xkme.2020.05.009_bib16","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1053\/j.ajkd.2004.07.022","article-title":"Coronary artery calcification in patients with CRF not undergoing dialysis","volume":"44","author":"Russo","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.xkme.2020.05.009_bib17","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/ki.2009.298","article-title":"Incidence and progression of coronary calcification in chronic kidney disease: the Multi-Ethnic Study of Atherosclerosis","volume":"76","author":"Kestenbaum","year":"2009","journal-title":"Kidney Int"},{"key":"10.1016\/j.xkme.2020.05.009_bib18","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1016\/j.amjcard.2012.07.044","article-title":"Risk factors for coronary artery calcium among patients with chronic kidney disease (from the Chronic Renal Insufficiency Cohort Study)","volume":"110","author":"He","year":"2012","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.xkme.2020.05.009_bib19","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1053\/j.ajkd.2011.04.024","article-title":"Relationship of estimated GFR and coronary artery calcification in the CRIC (Chronic Renal Insufficiency Cohort) Study","volume":"58","author":"Budoff","year":"2011","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.xkme.2020.05.009_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0272-6386(03)00905-3","article-title":"Bone metabolism and disease in chronic kidney disease","volume":"42 (suppl 3)","author":"Eknoyan","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.xkme.2020.05.009_bib21","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1159\/000098561","article-title":"Impact of ergocalciferol treatment of vitamin D deficiency on serum parathyroid hormone concentrations in chronic kidney disease","volume":"27","author":"Zisman","year":"2007","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.xkme.2020.05.009_bib22","doi-asserted-by":"crossref","first-page":"100","DOI":"10.5527\/wjn.v6.i3.100","article-title":"Role of different imaging modalities of vascular calcification in predicting outcomes in chronic kidney disease","volume":"6","author":"Disthabanchong","year":"2017","journal-title":"World J Nephrol"},{"key":"10.1016\/j.xkme.2020.05.009_bib23","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/0735-1097(90)90282-T","article-title":"Quantification of coronary artery calcium using ultrafast computed tomography","volume":"15","author":"Agatston","year":"1990","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.xkme.2020.05.009_bib24","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.2214\/ajr.182.5.1821327","article-title":"Evaluating changes in coronary artery calcium: an analytic method that accounts for interscan variability","volume":"182","author":"Hokanson","year":"2004","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.xkme.2020.05.009_bib25","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1093\/ndt\/gfh834","article-title":"1,25-Dihydroxyvitamin D3 but not cinacalcet HCl (Sensipar\u00ae\/Mimpara\u00ae) treatment mediates aortic calcification in a rat model of secondary hyperparathyroidism","volume":"20","author":"Henley","year":"2005","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.xkme.2020.05.009_bib26","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1359\/JBMR.051211","article-title":"Reversibility of calcitriol-induced medial artery calcification in rats with intact renal function","volume":"21","author":"Bas","year":"2006","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.xkme.2020.05.009_bib27","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1093\/ndt\/gfl098","article-title":"Arterial and cardiac disease in young adults with childhood-onset end-stage renal disease\u2014impact of calcium and vitamin D therapy","volume":"21","author":"Briese","year":"2006","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.xkme.2020.05.009_bib28","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.atherosclerosis.2018.02.009","article-title":"Risk factors for progression of coronary artery calcification in patients with chronic kidney disease: the CRIC study","volume":"271","author":"Bundy","year":"2018","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.xkme.2020.05.009_bib29","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1111\/j.1523-1755.2005.00522.x","article-title":"Progression of coronary artery calcification in diabetics with and without chronic kidney disease","volume":"68","author":"Mehrotra","year":"2005","journal-title":"Kidney Int"},{"key":"10.1016\/j.xkme.2020.05.009_bib30","first-page":"429","article-title":"Valvular calcification and its relationship to atherosclerosis in chronic kidney disease","volume":"18","author":"Leskinen","year":"2009","journal-title":"J\u00a0Heart Valve Dis"},{"key":"10.1016\/j.xkme.2020.05.009_bib31","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1007\/s10157-015-1104-4","article-title":"Cardiac valve calcification is associated with presence and severity of coronary artery disease in patients with pre-dialysis chronic kidney disease","volume":"19","author":"Kim","year":"2015","journal-title":"Clin Exp Nephrol"}],"container-title":["Kidney Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590059520301138?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590059520301138?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T01:20:59Z","timestamp":1762910459000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590059520301138"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":31,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["S2590059520301138"],"URL":"https:\/\/doi.org\/10.1016\/j.xkme.2020.05.009","relation":{},"ISSN":["2590-0595"],"issn-type":[{"value":"2590-0595","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vitamin D Analogues and Coronary Calcification in CKD Stages 3 and 4: A Randomized Controlled Trial of Calcitriol Versus Paricalcitol","name":"articletitle","label":"Article Title"},{"value":"Kidney Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xkme.2020.05.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier Inc. on behalf of the National Kidney Foundation, Inc.","name":"copyright","label":"Copyright"}]}}